Advances in pharmacology. Volume 23 /
ADVANCES IN PHARMACOLOGY VOL 23.
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
San Diego :
Academic Press,
�1992.
|
Colección: | Advances in pharmacology ;
v. 23 |
Temas: | |
Acceso en línea: | Texto completo Texto completo |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | SCIDIR_ocn367713992 | ||
003 | OCoLC | ||
005 | 20231117015308.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 090601s1992 cau ob 001 0 eng d | ||
040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d UBY |d IDEBK |d E7B |d OCLCQ |d OPELS |d OCLCQ |d OCLCF |d YDXCP |d EBLCP |d OCLCQ |d UAB |d MERUC |d OCLCQ |d OTZ |d OCLCQ |d LEAUB |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
019 | |a 505149404 |a 646756574 |a 808731422 | ||
020 | |a 9780080581149 |q (electronic bk.) | ||
020 | |a 0080581145 |q (electronic bk.) | ||
020 | |a 0120329239 |q (electronic bk.) | ||
020 | |a 9780120329236 |q (electronic bk.) | ||
035 | |a (OCoLC)367713992 |z (OCoLC)505149404 |z (OCoLC)646756574 |z (OCoLC)808731422 | ||
050 | 4 | |a RM101 |b .A38eb vol. 23 | |
072 | 7 | |a MED |x 023000 |2 bisacsh | |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
072 | 7 | |a MED |x 072000 |2 bisacsh | |
072 | 7 | |a MED |x 058170 |2 bisacsh | |
082 | 0 | 4 | |a 615/.1 |2 22 |
245 | 0 | 0 | |a Advances in pharmacology. |n Volume 23 / |c edited by J. Thomas August, M.W. Anders, Ferid Murad. |
260 | |a San Diego : |b Academic Press, |c �1992. | ||
300 | |a 1 online resource (348 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 0 | |a Advances in pharmacology ; |v v. 23 | |
504 | |a Includes bibliographical references and index. | ||
588 | 0 | |a Print version record. | |
505 | 0 | |a Front Cover; Advance in Pharmacology, Volume 23; Copyright Page; Contents; Contributors; Chapter 1. Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging; I. Introduction; II. Nonenzymatic Glycosylation; III. Advanced Glycosylation; IV. Biological Consequences of Advanced Glycosylation; V. Pharmacological Inhibition; VI. Conclusion; References; Chapter 2. Complex Carbohydrates in Drug Development; I. Introduction; II. Glycoconjugate Structure and Biosynthesis; III. Bioactivity and Pharmaceutical Potential of Complex Carbohydrates; IV. Conclusions and Perspectives. | |
505 | 8 | |a III. The Superoxide Radical: Toxicity versus ReactivityIV. The Pathological Production of Superoxide Radical; V. The Pharmacodynamics and Pharmacokinetics of the Superoxide Dismutases; VI. Chemical Modification of Superoxide Dismutases; VII. Genetic Modification of Superoxide Dismutases; VIII. Down Syndrome and the Concept of "Oxidant-Antioxidant Balance"; IX. Concluding Remarks; References; Chapter 5. Pharmacological Implications of Interleukin-5 in the Control of Eosinophilia; I. Introduction; II. Biochemistry of Interleukin-5; III. Biological Properties of Interleukin-5. | |
505 | 8 | |a IV. Control of EosinophiliaV. Eosinophils and Tumors; VI. Eosinophils and Asthma; VII. Summary and Overview; References; Chapter 6. Advances in Antiarrhythmic Drug Therapy; I. Introduction; II. Classification of Antiarrhythmic Drugs; III. Applications of Classification Systems; IV. Class I Antiarrhythmic Drugs; V. Class II Antiarrhythmic Drugs; VI. Class III Antiarrhythmic Drugs; References; Chapter 7. New Developments in Thrombolytic Therapy; I. Introduction; II. Currently Available Plasminogen Activators; III. Antibody-Directed Thrombolysis. | |
505 | 8 | |a LV. Plasminogen Plus Plasminogen Activator CombinationsV. Thrombolysis and Anticoagulation; VI. Thrombolysis and Platelets; VII. Combinations of Plasminogen Activators; VIII. Summary; References; Chapter 8. Therapy of Hematopoietic Disorders with Recombinant Colony-Stimulating Factors; I. Overview of Normal Hematopoiesis; II. Pharmacologic Principles of Colony-Stimulating Factor Therapy; III. Clinical Uses of Colony-Stimulating Factors; Refcrences; Chapter 9. Mechanisms of Xenobiotic-Induced Renal Carcinogenicity; I. Introduction; II. Anatomy, Physiology, and Biochemistry of the Kidney. | |
520 | |a ADVANCES IN PHARMACOLOGY VOL 23. | ||
650 | 0 | |a Pharmacology. | |
650 | 2 | |a Pharmacology |0 (DNLM)D010600 | |
650 | 6 | |a Pharmacologie. |0 (CaQQLa)201-0007219 | |
650 | 7 | |a pharmacology. |2 aat |0 (CStmoGRI)aat300137970 | |
650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
650 | 7 | |a Pharmacology |2 fast |0 (OCoLC)fst01060259 | |
653 | 0 | |a Medicine | |
700 | 1 | |a August, J. Thomas. | |
700 | 1 | |a Anders, M. W. |q (Marion Walter), |d 1936- | |
700 | 1 | |a Murad, Ferid. | |
776 | 0 | 8 | |i Print version: |t Advances in pharmacology. Volume 23. |d San Diego : Academic Press, �1992 |z 0120329239 |z 9780120329236 |w (OCoLC)26306838 |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120329236 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/10543589/23 |z Texto completo |